Comparing Inflammatory Markers in Patients With and Without Depression With Chronic Periodontitis

Sponsor
University of Alabama at Birmingham (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT03553095
Collaborator
(none)
92
1
3
53.6
1.7

Study Details

Study Description

Brief Summary

This study will evaluate whether use of antidepressants can reduce gingival inflammation in patients with periodontal (gum) disease.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Periodontal Surgery
N/A

Detailed Description

The primary purpose of this study is to evaluate whether use of antidepressants can reduce gingival inflammation in patients with periodontal (gum) disease. This study will also investigate the link between oral and systemic inflammation in patients diagnosed with depression and periodontal disease. Researcher will collect gingival crevicular fluid, plaque, tissue and blood serum samples to evaluate the link between these two diseases. The collection of gingival crevicular fluid, plaque and blood serum is relatively non-invasive, elicits minimal discomfort and does not require use of any anesthesia. The soft tissue sample will be collected as part of an otherwise planned periodontal surgical procedure under local anesthesia. In periodontal therapy (surgical procedures i.e. gum surgery, tooth extraction and or dental implant surgery) there is enough availability of remnant tissue for the collection of samples, which is otherwise discarded.

Study Design

Study Type:
Interventional
Actual Enrollment :
92 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Basic Science
Official Title:
Comparing Inflammatory Markers in Patients With and Without Depression With Chronic Periodontitis
Actual Study Start Date :
Jul 12, 2018
Actual Primary Completion Date :
Dec 30, 2019
Anticipated Study Completion Date :
Dec 30, 2022

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Chronic Periodontitis and Depression Medications

Patients with clinically diagnosed depression taking (SSRIs, NDRIs, SNRIs, tricyclic antidepressants) and with chronic periodontitis

Procedure: Periodontal Surgery
Samples will be collected from patient in need of periodontal therapy (surgical procedures i.e. gum surgery, tooth extraction and or dental implant surgery). As standard during this procedures remnant tissue is otherwise discarded.

Active Comparator: Chronic Periodontitis without Depression Medications

Patients with clinically diagnosed depression not taking any antidepressants (SSRIs NDRIs, SNRIs and Tricyclic antidepressants) and with chronic periodontitis

Procedure: Periodontal Surgery
Samples will be collected from patient in need of periodontal therapy (surgical procedures i.e. gum surgery, tooth extraction and or dental implant surgery). As standard during this procedures remnant tissue is otherwise discarded.

Active Comparator: Chronic Periodontitis

Patients without depression, not taking any antidepressants and with chronic periodontitis

Procedure: Periodontal Surgery
Samples will be collected from patient in need of periodontal therapy (surgical procedures i.e. gum surgery, tooth extraction and or dental implant surgery). As standard during this procedures remnant tissue is otherwise discarded.

Outcome Measures

Primary Outcome Measures

  1. Gingival crevicular fluid (GCF) [baseline to 1 week]

    Measuring oral inflammatory markers in Gingival crevicular fluid (GCF) in patient with chronic periodontitis.

Secondary Outcome Measures

  1. Plaque [baseline to 1 week]

    Analyze the type of bacteria that is present in patient with chronic periodontitis.

Other Outcome Measures

  1. Soft tissue [baseline to 1 week]

    Analyze the immune cells in patient with chronic periodontitis.

  2. Blood Serum [baseline to 1 week]

    Analyze the systemic inflammatory markers in patient with chronic periodontitis.

  3. Patient Health Questionnaire 8 (PHQ8) [baseline to 1 week]

    Measure depression status in patient with chronic periodontitis.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 99 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • At least 18 years old

  • Must be a patient of the UAB Dental School

  • Able to read and understand informed consent document

  • Good general health as evidenced by medical history

  • Minimum of 18 teeth, excluding third molars

  • Having moderate to severe periodontal disease according to AAP definition (teeth ≥5 mm PD and ≥3 mm CAL)

  • Having >30 percent bleeding sites upon probing

  • Patients taking depression medication with chronic periodontitis

  • Patients without depression with chronic periodontitis

  • Patients who have not had a dental cleaning in the past 3 months prior to procedure

  • Patients scheduled for surgical procedures (i.e. gum surgery, tooth extraction, or dental implants)

Exclusion Criteria:
  • Non-English speaking

  • Less than 18 years old

  • Smokers/tobacco users (>10 cigarettes/day)

  • Any dental condition that requires immediate treatment, such as emergency care

  • Chronic use (≥3 times/week) of anti-inflammatory medications (e.g., non-steroidal anti-inflammatory drugs, steroids). Low-dose aspirin (less than 325 mg daily)

  • Immunocompromised subjects

  • Any medical history or any concomitant medication that might affect the assessment of the study treatment or periodontal tissues, such as uncontrolled diabetes, nifedipine, phenytoin (Dilantin), subjects with arthritis and morbidly obese (BMI ≥ 40)

Contacts and Locations

Locations

Site City State Country Postal Code
1 Unversity of Alabama at Birmingham, School of Dentistry Birmingham Alabama United States 35294-0007

Sponsors and Collaborators

  • University of Alabama at Birmingham

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Maninder Kaur, Principal Investigator, University of Alabama at Birmingham
ClinicalTrials.gov Identifier:
NCT03553095
Other Study ID Numbers:
  • IRB-300000426
First Posted:
Jun 12, 2018
Last Update Posted:
Mar 11, 2022
Last Verified:
Mar 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 11, 2022